The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
Haemostatic changes in pregnancy
Open accessAbstract
In normal pregnancy, there is a marked increase in the procoagulant activity in maternal blood characterized by elevation of factors VII, X, VIII, fibrinogen and von Willebrand factor, which is maximal around term. This is associated with an increase in prothrombin fragments (PF1+2) and thrombin-antithrombin complexes. There is a decrease in physiological anticoagulants manifested by a significant reduction in protein S activity and by acquired activated protein C (APC) resistance. The overall fibrinolytic activity is impaired during pregnancy, but returns rapidly to normal following delivery. This is largely due to placental derived plasminogen activator inhibitor type 2 (PAI-2), which is present in substantial quantities during pregnancy. D-dimer, a specific marker of fibrinolysis resulting from breakdown of cross-linked fibrin polymer by plasmin, increases as pregnancy progresses. Overall, there is a 4- to 10-fold increased thrombotic risk throughout gestation and the postpartum period. Local haemostasis at the placental throphoblast level is characterized by increased tissue factor (TF) expression and low expression of the inhibitor TFPI. Microparticles derived from maternal endothelial cells and platelets, and from placental throphoblasts may contribute to the procoagulant effect. Local anticoagulant mechanisms on placental throphoblasts are important for counterbalance of the procoagulant milieu. Disruption of anticoagulant mechanisms, for example, autoantibodies, to annexin V may increase pregnancy complications in patients with antiphospholipid antibodies (APLA).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutation in blood coagulation factor V associated with resistance to activated protein C
Bertina, R. M., Koeleman, B. P. C., Koster, T., Rosendaal, F. R., Dirven, R. J., de Ronde, H., van der Velden, P. A., & Reitsma, P. H. (1994) · Nature · doi:10.1038/369064a0 · Cited by 3,783
Dahlbäck, B., Carlsson, M., & Svensson, P. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.3.1004 · Cited by 1,945
Mallat, Z., Benamer, H., Hugel, B., Benessiano, J., Steg, P. G., Freyssinet, J.-M., & Tedgui, A. (2000) · Circulation · doi:10.1161/01.cir.101.8.841 · Cited by 883
Falati, S., Liu, Q., Gross, P., Merrill-Skoloff, G., Chou, J., Vandendries, E., Celi, A., Croce, K., Furie, B. C., & Furie, B. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021868 · Cited by 752
Combes, V., Simon, A.-C., Grau, G.-E., Arnoux, D., Camoin, L., Sabatier, F., Mutin, M., Sanmarco, M., Sampol, J., & Dignat-George, F. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4985 · Cited by 732
Microparticles in cardiovascular diseases
VANWIJK, M., VANBAVEL, E., STURK, A., & NIEUWLAND, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00367-5 · Cited by 610
Haemostasis in Normal Pregnancy
Stirling, Y., Woolf, L., North, W. R. S., Seghatchian, M. J., & Meade, T. W. (1984) · Thrombosis and Haemostasis · doi:10.1055/s-0038-1661167 · Cited by 600
Knight, M., Redman, C. W. G., Linton, E. A., & Sargent, I. L. (1998) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1998.tb10178.x · Cited by 494
Activated Protein C Sensitivity, Protein C, Protein S and Coagulation in Normal Pregnancy
Brennand, J., Conkie, J. A., McCall, F., Greer, I. A., Walker, I., & Clark, P. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615035 · Cited by 386
Functional and immunologic protein S levels are decreased during pregnancy
Comp, P., Thurnau, G., Welsh, J., & Esmon, C. (1986) · Blood · doi:10.1182/blood.v68.4.881.881 · Cited by 353
Fibrinolysis in pregnancy: a study of plasminogen activator inhibitors
Kruithof, E., Tran-Thang, C., Gudinchet, A., Hauert, J., Nicoloso, G., Genton, C., Welti, H., & Bachmann, F. (1987) · Blood · doi:10.1182/blood.v69.2.460.460 · Cited by 338
Enhanced thrombin generation in normal and hypertensive pregnancy
de Boer, K., ten Cate, J. W., Sturk, A., Borm, J. J. J., & Treffers, P. E. (1989) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(89)90096-3 · Cited by 231
Activated Protein C Resistance (FV:Q506) and Pregnancy
Lindqvist, P. G., Svensson, P. J., Maršál, K., Grennert, L., Luterkort, M., & Dahlbäck, B. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614519 · Cited by 216
Development of resistance to activated protein C during pregnancy
CUMMING, A. M., TAIT, R. C., FILDES, S., YOONG, A., KEENEY, S., & HAY, C. R. M. (1995) · British Journal of Haematology · doi:10.1111/j.1365-2141.1995.tb05610.x · Cited by 197
APC Resistance and other Haemostatic Variables during Pregnancy and Puerperium
Kjellberg, U., Andersson, N.-E., Rosén, S., Tengborn, L., & Hellgren, M. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614518 · Cited by 163
Bretelle, F., Sabatier, F., Desprez, D., Camoin‐Jau, L., Grunebaum, L., Combes, V., D’Ercole, C., & Dignat‐George, F. (2003) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613378 · Cited by 148
VanWijk, M. J., Nieuwland, R., Boer, K., van der Post, J., VanBavel, E., & Sturk, A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.124279 · Cited by 147
Enhanced thrombin generation and fibrinolytic activity in normal pregnancy and the puerperium.
Bremme, K. A., Östlund, E., Almqvist, I., Heinonen, K., & Blombäck, M. (1992) · PubMed · Cited by 144
Changes in protein C and protein S levels in normal pregnancy
Faught, W., Garner, P. R., Jones, G., & Ivey, B. (1995) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(95)90104-3 · Cited by 134
Circulating Procoagulant Microparticles in Women with Unexplained Pregnancy Loss: a New Insight
Laude, I., Rongières-Bertrand, C., Boyer‐Neumann, C., Wolf, M., Mairovitz, V., Hugel, B., Freyssinet, J., Frydman, R., Eschwège, V., & Meyer, D. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612657 · Cited by 129
VanWijk, M. J., Švedas, E., Boer, K., Nieuwland, R., VanBavel, E., & Kublickiene, K. R. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.127905 · Cited by 114
Weltermann, A., Philipp, K., Hafner, E., Kaider, A., Kittl, E.-M., Brenner, B., Mannhalter, C., Lechner, K., Kyrle, P. A., & Eichinger, S. (1999) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1614366 · Cited by 113
Self-citationBrenner, B., Katz, T., Miyagi, Y., Lanir, N., & Aharon, A. (2004) · Thrombosis and Haemostasis · doi:10.1160/th04-01-0033 · Cited by 94
Self-citationShould anticardiolipin tests be performed in otherwise healthy pregnant women?
Harris, E. N., & Spinnato, J. A. (1991) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(12)90741-3 · Cited by 93
Wright, J. G., COOPER, P. C., Åstedt, B., Lecander, I., Wilde, J., Preston, F. E., & Greaves, M. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb07630.x · Cited by 84
Boer, K., Berckmans, R. J., Meijers, J. C. M., van der Post, J., Sturk, A., VanBavel, E., Nieuwland, R., & van Wijk, M. J. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613231 · Cited by 72
The coagulation and fibrinolytic enzyme system in pregnancy and in the puerperium
Beller, F. K., & Ebert, C. (1982) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/0028-2243(82)90028-4 · Cited by 68
Sattar, N. A., Walker, I., Greer, I. A., & Clark, P. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1612659 · Cited by 58
Gilabert, J., Fernández, J. A., España, F., et al. (1988) · Thrombosis Research · doi:10.1016/0049-3848(88)90312-x · Cited by 58
Predictive Value of Plasma Thrombomodulin in Preeclampsia and Gestational Hypertension
Valsecchi, L., Fausto, A., Gozin, D., D’Angelo, S. V., Safa, O., Castiglioni, M. T., Amiral, J., D’Angelo, A., & Boffa, M. (1998) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1615021 · Cited by 53
Comparison of protein S functional and antigenic assays in normal pregnancy
Lefkowitz, Clarke, & Barbour (1996) · American Journal of Obstetrics and Gynecology · doi:10.1053/ob.1996.v175.a73866 · Cited by 42
The prevalence of autoantibodies and lupus anticoagulant in healthy pregnant women.
El-Roeiy, A., Myers, S. A., & Gleicher, N. (1990) · PubMed · Cited by 42
Craven, C., Chedwick, L., & Ward, K. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.119717 · Cited by 32
Lockwood, C. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.1.297 · Cited by 31
Cited by
ESC Guidelines on the management of cardiovascular diseases during pregnancy
Endorsed by the European Society of Gynecology (ESG), T. A. F. E. P. C. (., Authors/Task Force Members, Regitz-Zagrosek, V., Blomstrom Lundqvist, C., Borghi, C., Cifkova, R., Ferreira, R., Foidart, J.-M., Gibbs, J. S. R., Gohlke-Baerwolf, C., et al. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehr218 · Cited by 1,924
Sex differences in stroke: epidemiology, clinical presentation, medical care, and outcomes
Reeves, M. J., Bushnell, C. D., Howard, G., Gargano, J. W., Duncan, P. W., Lynch, G., Khatiwoda, A., & Lisabeth, L. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70193-5 · Cited by 1,362
The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage
CHARBIT, B., MANDELBROT, L., SAMAIN, E., BARON, G., HADDAOUI, B., KEITA, H., SIBONY, O., MAHIEU‐CAPUTO, D., HURTAUD‐ROUX, M. F., HUISSE, M. G., et al. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02297.x · Cited by 762
Epidemiology and prevention of venous thromboembolism
Lutsey, P. L., & Zakai, N. A. (2023) · Nature Reviews Cardiology · doi:10.1038/s41569-022-00787-6 · Cited by 507
Alterations in Physiology and Anatomy during Pregnancy
Tan, E. K., & Tan, E. L. (2013) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2013.08.001 · Cited by 484
Metadata
- Authors
- Brenner, B.
- Venue
- Thrombosis Research
- Publisher
- Elsevier BV
- Published
- 2004-01
- Volume
- 114
- Issue
- 5-6
- Pages
- 409-414
- ISSN
- 0049-3848 (ISSN-L)
- OpenAlex
- W2064985699
- Cited by
- 596
- References
- 34
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.